OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pooled Analysis of Tobacco Use and Risk of Parkinson Disease
Beate Ritz, Alberto Ascherio, Harvey Checkoway, et al.
Archives of Neurology (2007) Vol. 64, Iss. 7, pp. 990-990
Open Access | Times Cited: 334
Beate Ritz, Alberto Ascherio, Harvey Checkoway, et al.
Archives of Neurology (2007) Vol. 64, Iss. 7, pp. 990-990
Open Access | Times Cited: 334
Showing 1-25 of 334 citing articles:
Epidemiology and etiology of Parkinson’s disease: a review of the evidence
Karin Wirdefeldt, Hans‐Olov Adami, Philip Cole, et al.
European Journal of Epidemiology (2011) Vol. 26, Iss. S1, pp. 1-58
Open Access | Times Cited: 1148
Karin Wirdefeldt, Hans‐Olov Adami, Philip Cole, et al.
European Journal of Epidemiology (2011) Vol. 26, Iss. S1, pp. 1-58
Open Access | Times Cited: 1148
Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology
David K. Simon, Caroline M. Tanner, Patrik Brundin
Clinics in Geriatric Medicine (2019) Vol. 36, Iss. 1, pp. 1-12
Open Access | Times Cited: 793
David K. Simon, Caroline M. Tanner, Patrik Brundin
Clinics in Geriatric Medicine (2019) Vol. 36, Iss. 1, pp. 1-12
Open Access | Times Cited: 793
Inflammation and immune dysfunction in Parkinson disease
Malú G. Tansey, Rebecca L. Wallings, Madelyn C. Houser, et al.
Nature reviews. Immunology (2022) Vol. 22, Iss. 11, pp. 657-673
Open Access | Times Cited: 775
Malú G. Tansey, Rebecca L. Wallings, Madelyn C. Houser, et al.
Nature reviews. Immunology (2022) Vol. 22, Iss. 11, pp. 657-673
Open Access | Times Cited: 775
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
José Á. Obeso, María Stamelou, Christopher G. Goetz, et al.
Movement Disorders (2017) Vol. 32, Iss. 9, pp. 1264-1310
Open Access | Times Cited: 712
José Á. Obeso, María Stamelou, Christopher G. Goetz, et al.
Movement Disorders (2017) Vol. 32, Iss. 9, pp. 1264-1310
Open Access | Times Cited: 712
Meta‐analysis of early nonmotor features and risk factors for Parkinson disease
Alastair Noyce, Jonathan P. Bestwick, Laura Silveira‐Moriyama, et al.
Annals of Neurology (2012) Vol. 72, Iss. 6, pp. 893-901
Open Access | Times Cited: 710
Alastair Noyce, Jonathan P. Bestwick, Laura Silveira‐Moriyama, et al.
Annals of Neurology (2012) Vol. 72, Iss. 6, pp. 893-901
Open Access | Times Cited: 710
Neurotoxin-based models of Parkinson's disease
Jordi Bové, Céline Perier
Neuroscience (2011) Vol. 211, pp. 51-76
Closed Access | Times Cited: 483
Jordi Bové, Céline Perier
Neuroscience (2011) Vol. 211, pp. 51-76
Closed Access | Times Cited: 483
β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s disease
Shuchi Mittal, Kjetil Bjørnevik, Doo Soon Im, et al.
Science (2017) Vol. 357, Iss. 6354, pp. 891-898
Open Access | Times Cited: 389
Shuchi Mittal, Kjetil Bjørnevik, Doo Soon Im, et al.
Science (2017) Vol. 357, Iss. 6354, pp. 891-898
Open Access | Times Cited: 389
Medical records documentation of constipation preceding Parkinson disease
Rodolfo Savica, J. M. Carlin, Brandon R. Grossardt, et al.
Neurology (2009) Vol. 73, Iss. 21, pp. 1752-1758
Open Access | Times Cited: 382
Rodolfo Savica, J. M. Carlin, Brandon R. Grossardt, et al.
Neurology (2009) Vol. 73, Iss. 21, pp. 1752-1758
Open Access | Times Cited: 382
Environmental risk factors and Parkinson's disease: An umbrella review of meta-analyses
Vanesa Bellou, Lazaros Belbasis, Ioanna Tzoulaki, et al.
Parkinsonism & Related Disorders (2015) Vol. 23, pp. 1-9
Open Access | Times Cited: 362
Vanesa Bellou, Lazaros Belbasis, Ioanna Tzoulaki, et al.
Parkinsonism & Related Disorders (2015) Vol. 23, pp. 1-9
Open Access | Times Cited: 362
Epidemiology of Parkinson's disease
Alexis Elbaz, Laure Carcaillon‐Bentata, Sofiane Kab, et al.
Revue Neurologique (2015) Vol. 172, Iss. 1, pp. 14-26
Closed Access | Times Cited: 362
Alexis Elbaz, Laure Carcaillon‐Bentata, Sofiane Kab, et al.
Revue Neurologique (2015) Vol. 172, Iss. 1, pp. 14-26
Closed Access | Times Cited: 362
Parkinson’s Disease: Etiology, Neuropathology, and Pathogenesis
Antonina Kouli, Kelli Torsney, Wei‐Li Kuan
Codon Publications eBooks (2018), pp. 3-26
Open Access | Times Cited: 357
Antonina Kouli, Kelli Torsney, Wei‐Li Kuan
Codon Publications eBooks (2018), pp. 3-26
Open Access | Times Cited: 357
Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
Richard M. Meade, David P. Fairlie, Jody M. Mason
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 346
Richard M. Meade, David P. Fairlie, Jody M. Mason
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 346
Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases
Lucia Migliore, Fabio Coppedè
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis (2008) Vol. 667, Iss. 1-2, pp. 82-97
Closed Access | Times Cited: 293
Lucia Migliore, Fabio Coppedè
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis (2008) Vol. 667, Iss. 1-2, pp. 82-97
Closed Access | Times Cited: 293
Exposure to pesticides or solvents and risk of Parkinson disease
Gianni Pezzoli, Emanuele Cereda
Neurology (2013) Vol. 80, Iss. 22, pp. 2035-2041
Closed Access | Times Cited: 292
Gianni Pezzoli, Emanuele Cereda
Neurology (2013) Vol. 80, Iss. 22, pp. 2035-2041
Closed Access | Times Cited: 292
The epidemiology of Parkinson's disease
Yoav Ben‐Shlomo, Sirwan K.L. Darweesh, Jorge J. Llibre‐Guerra, et al.
The Lancet (2024) Vol. 403, Iss. 10423, pp. 283-292
Closed Access | Times Cited: 286
Yoav Ben‐Shlomo, Sirwan K.L. Darweesh, Jorge J. Llibre‐Guerra, et al.
The Lancet (2024) Vol. 403, Iss. 10423, pp. 283-292
Closed Access | Times Cited: 286
Integrating Pathways of Parkinson's Disease in a Molecular Interaction Map
Kazuhiro Fujita, Marek Ostaszewski, Yukiko Matsuoka, et al.
Molecular Neurobiology (2013) Vol. 49, Iss. 1, pp. 88-102
Open Access | Times Cited: 265
Kazuhiro Fujita, Marek Ostaszewski, Yukiko Matsuoka, et al.
Molecular Neurobiology (2013) Vol. 49, Iss. 1, pp. 88-102
Open Access | Times Cited: 265
Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs
Russell C. Callaghan, James K. Cunningham, Jenna Sykes, et al.
Drug and Alcohol Dependence (2011) Vol. 120, Iss. 1-3, pp. 35-40
Closed Access | Times Cited: 260
Russell C. Callaghan, James K. Cunningham, Jenna Sykes, et al.
Drug and Alcohol Dependence (2011) Vol. 120, Iss. 1-3, pp. 35-40
Closed Access | Times Cited: 260
Nicotine as a potential neuroprotective agent for Parkinson's disease
Maryka Quik, Xiomara A. Perez, Tanuja Bordia
Movement Disorders (2012) Vol. 27, Iss. 8, pp. 947-957
Open Access | Times Cited: 233
Maryka Quik, Xiomara A. Perez, Tanuja Bordia
Movement Disorders (2012) Vol. 27, Iss. 8, pp. 947-957
Open Access | Times Cited: 233
Dose–response meta‐analysis on coffee, tea and caffeine consumption with risk of P arkinson's disease
Huijun Qi, Shixue Li
Geriatrics and gerontology international/Geriatrics & gerontology international (2013) Vol. 14, Iss. 2, pp. 430-439
Closed Access | Times Cited: 209
Huijun Qi, Shixue Li
Geriatrics and gerontology international/Geriatrics & gerontology international (2013) Vol. 14, Iss. 2, pp. 430-439
Closed Access | Times Cited: 209
Association between Parkinson’s Disease and Cigarette Smoking, Rural Living, Well-Water Consumption, Farming and Pesticide Use: Systematic Review and Meta-Analysis
Charles B. Breckenridge, Colin Berry, Ellen T. Chang, et al.
PLoS ONE (2016) Vol. 11, Iss. 4, pp. e0151841-e0151841
Open Access | Times Cited: 204
Charles B. Breckenridge, Colin Berry, Ellen T. Chang, et al.
PLoS ONE (2016) Vol. 11, Iss. 4, pp. e0151841-e0151841
Open Access | Times Cited: 204
Calcium and Parkinson's disease
D. James Surmeier, Paul T. Schumacker, Jaime Díaz Guzmán, et al.
Biochemical and Biophysical Research Communications (2016) Vol. 483, Iss. 4, pp. 1013-1019
Open Access | Times Cited: 180
D. James Surmeier, Paul T. Schumacker, Jaime Díaz Guzmán, et al.
Biochemical and Biophysical Research Communications (2016) Vol. 483, Iss. 4, pp. 1013-1019
Open Access | Times Cited: 180
The lipopolysaccharide Parkinson’s disease animal model: mechanistic studies and drug discovery
Garima Dutta, Ping Zhang, Bin Liu
Fundamental and Clinical Pharmacology (2008) Vol. 22, Iss. 5, pp. 453-464
Open Access | Times Cited: 223
Garima Dutta, Ping Zhang, Bin Liu
Fundamental and Clinical Pharmacology (2008) Vol. 22, Iss. 5, pp. 453-464
Open Access | Times Cited: 223
Smoking, nicotine and neuropsychiatric disorders
Péter Döme, Judit Lazáry, Miklós Péter Kalapos, et al.
Neuroscience & Biobehavioral Reviews (2009) Vol. 34, Iss. 3, pp. 295-342
Closed Access | Times Cited: 212
Péter Döme, Judit Lazáry, Miklós Péter Kalapos, et al.
Neuroscience & Biobehavioral Reviews (2009) Vol. 34, Iss. 3, pp. 295-342
Closed Access | Times Cited: 212
Smoking duration, intensity, and risk of Parkinson disease
Honglei Chen, Xuemei Huang, Xu‐Guang Guo, et al.
Neurology (2010) Vol. 74, Iss. 11, pp. 878-884
Open Access | Times Cited: 211
Honglei Chen, Xuemei Huang, Xu‐Guang Guo, et al.
Neurology (2010) Vol. 74, Iss. 11, pp. 878-884
Open Access | Times Cited: 211
Neural Systems Governed by Nicotinic Acetylcholine Receptors: Emerging Hypotheses
Julie M. Miwa, Robert Freedman, Henry A. Lester
Neuron (2011) Vol. 70, Iss. 1, pp. 20-33
Open Access | Times Cited: 199
Julie M. Miwa, Robert Freedman, Henry A. Lester
Neuron (2011) Vol. 70, Iss. 1, pp. 20-33
Open Access | Times Cited: 199
